复合药房的广告和营销:许多灰色的阴影
1Brown & Fortunato, P.C., Amarillo and Dallas, Texas. AHobbs@BF-Law.com.
International journal of pharmaceutical compounding
|March 31, 2025
概括
复合药物的广告缺乏明确的FDA指导方针,导致药房不一致的执法和危险的营销策略. 这篇文章澄清了历史背景,并为合规广告和风险评估提供了指导.
科学领域:
- 药品广告的规定 药品广告的规定
- 营销复合药物的药物营销.
背景情况:
- 经FDA批准的药物广告受到严格监管,有明确的指导方针.
- 复合药物的广告规定是模两可的,令人困惑的,并且执行不一致.
研究的目的:
- 探索复合药物广告中含糊不清的历史原因.
- 为制定合规的复合药品广告提供准则.
- 帮助药房评估执法行动的风险.
主要方法:
- 对历史监管框架的分析.
- 审查执法行动和行业实践.
- 开发风险评估策略.
主要成果:
- 确定了导致监管不确定性的历史因素.
- 概述了复合药房广告中的常见陷.
- 提出了一个风险评估框架.
结论:
- 由于广告法律不清楚,复合药房面临重大挑战.
- 遵守特定的指导方针可以减轻风险.
- 需要进一步澄清法规.
相关概念视频
Prescription, Nonprescription and Orphan Drugs
666
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
666
Biopharmaceutics and Pharmacokinetics: Overview
1.8K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.8K
Drug Delivery: Parenteral Route
341
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
341
Drug Dosage Regimen: Overview
3.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.4K
Prodrugs
2.3K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.3K
Drug Nomenclature
1.5K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.5K


